What is the age limit for Jivi?

Learn about possible savings and co-pay support for Jivi ®. EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs).

What are the contraindications for Jivi?

EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs). Jivi is not indicated for the treatment of von Willebrand disease.

Jivi User Guide - Finder Manual

Q: What is Jivi used to treat?

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A.

Q: How do I contact the FDA about Jivi antihemophilic factor?

Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for:

Listing Results Jivi User Guide

About 15 results and 4 answers.

JIVI FDA

Jivi, antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …
user guide

Jivi - FDA prescribing information, side effects and uses

Hypersensitivity ReactionsHypersensitivity reactions, including severe allergic reactions, have occurred with Jivi. Monitor patients for hypersensitivity symptoms. Early signs of hypersensitivity reactions, which can progress to anaphylaxis, may include chest or throat tightness, dizziness, mild hypotension and …
Neutralizing AntibodiesNeutralizing antibody (inhibitor) formation can occur following administration of Jivi. Carefully monitor patients for the development of Factor VIII inhibitors, using appropriate clinical observations and laboratory tests. If expected plasma Factor VIII activity levels are not attained …
Gray: 3000 IU with 2.5 mL SWFI
Red: 1000 IU with 2.5 mL SWFI
Green: 500 IU with 2.5 mL SWFI
Yellow: 2000 IU with 2.5 mL SWFI

Jivi® Official Healthcare Professionals Site

Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …
user guide

Home

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in …
user guide

Jivi Dosage Guide - Drugs.com

Warm both unopened Jivi vial and prefilled diluent syringe in your hands to a comfortable temperature (do not exceed 37°C or 99°F). 1. Remove the protective cap from the …

Jivi , PEGylated-aucl

Sep 07, 2018 . What is Jivi? Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A (congenital Factor VIII …
user guide

Official Jive Mini Pods Instructions - YouTube

Received these directly From Jive Mini Pods Support teamIncluded are their official instructions that would save them lots of headaches if they had just incl...

K++ V2 Flight Controller User Manual

1. This manual needs to be used in conjunction with the corresponding assistant software. If there is any discrepancy with the assistant software, please refer to the assistant …
Jivi

Jivi - Side Effects, Interactions, Uses, Dosage, Warnings

How to take Jivi (Intravenous)? Use Jivi (Intravenous) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer …

Ordering and billing for Jivi® antihemophilic factor

Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …

Documentation - Jive Software

Ask questions. Make feature requests. Report documentation-related bugs. With the Jive Documentation space in the Jive Community, we make tech support easy.

GoTo Connect, formerly Jive - GoTo Connect Support

GoTo support is here to help! Browse help articles, video tutorials, user guides, and other resources to learn more about using GoTo Connect.

Frequently Asked Questions

What is Jivi used to treat?

Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A.
How do I contact the FDA about Jivi antihemophilic factor?

Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for:
What is the age limit for Jivi?

Learn about possible savings and co-pay support for Jivi®. EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs).
What are the contraindications for Jivi?

EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs). Jivi is not indicated for the treatment of von Willebrand disease.